The success of myoblast transplantation in clinical trials has been limited in part by the low dispersion of grafted cells outside the injection site. Our research group previously reported that the culture of myoblasts with concanavalin A, a stimulator of metalloproteinase production, increased their migration. Several lines of evidence also suggested that muscle cell fusion involves metalloproteinase-sensitive mechanisms. To determine whether the increased expression of metalloproteinases had an influence on myoblast fusion and dispersion through the muscle following transplantation, we generated a myoblast cell line expressing human matrilysin (MMP-7). The MMP-7-expressing myoblasts were obtained by the stable transfection of a matrilysin expression vector in a TnlLacZ immortomouse myoblast clone. Matrilysin-expressing myoblasts showed a highly increased in vitro fusion index, forming seven times (p < 0.001) more myotubes than the control cell line and three times (p < 0.001) more myotubes than the Immortomyoblast parental clone. Singlesite transplantation of matrilysin-expressing myoblasts generated more fibers (p < 0.001), over a greater surface (p < 0.001) than the control cell line. The cotransplantation of matrilysin-expressing myoblasts and of normal human myoblasts in SCID mice increased the number of human dystrophin-positive fibers and myotubes by sixfold. Although no significant increased migration of myoblasts outside the injection sites was observed, our results show that the metalloproteinase activity can improve the myogenic potential of myoblasts in vitro and the fusion of myoblasts with host fibers in vivo. MMP-7 expression may be useful in increasing myoblast transplantation success.
INTRODUCTION
Duchenne muscular dystrophy is a hereditary disease caused by a mutation located on the X chromosome, which is responsible for the absence of functional dys trophin in the muscle fibers (27, 28) . Myoblast transplan tation is a potential treatment for Duchenne muscular dystrophy (DMD), other hereditary recessive myopa thies, and many hereditary diseases (2, 35) . Several groups have tried myoblast transplantation, but most clinical trials achieved little success in the treatment of DMD patients (17, 19, 29, 32, 40, 41) . Groups involved in myoblast transplantation have identified three types of problems that can account for the limited success in past clinical trials: 1) the specific immune response, 2) a lim ited diffusion of the transplanted myoblasts, and 3) an inflammatory response responsible for a rapid death of transplanted cells. Although anti-inflammatory drugs, adhesion molecule antibodies, and immunosuppressive agents can decrease the immune system response against the grafted cells, little progress has been achieved in stimulating myoblast diffusion in the muscle tissue. In jected myoblasts remain near the injection site and do not spread (39) . Large amounts of dystrophin-positive fibers were observed in muscles previously damaged and irradiated to prevent regeneration by host myoblasts (26, 31, 42) . High percentage regeneration and significant myoblast movement from the injection site require the use of previously irradiated host muscle, severe mechan ical injury, or injection of notexin (43) . It is, however, questionable whether such damages could be inflicted in clinical studies. Some reports also have shown significant migration of C 2 C| 2 myoblasts away from the injection site (43, 44) . This is, however, an immortal cell line that probably has some tumorigenic properties such as abnormal metallo proteinase (MMP) secretion. A threefold increase of in tramuscular migration of myoblasts obtained from pri mary cultures was achieved by our group by the addition of concanavalin A to the culture medium (23) . This aug-mentation was attributed to an additional MMP expres sion (23, 34) . MMPs are involved in the normal tissue turnover and remodulation during growth and develop ment (6) . To overcome extracellular matrix (ECM) bar riers, advancing cells must secrete proteases such as MMPs or protease activators such as urokinase at their leading edge, where complex proteolysis can direct mi gration, preserve ECM attachment, and avoid unwanted tissue damage. It is still unclear whether proteases re move physical barriers or if they modify the ECM in such a way that it is suitable for migration (13) . How ever, MMPs are found in abundance in their inactive precursor form in normal tissues and fluids, suggesting that their activities are limited by physiological activa tion rather than by expression alone (38) . These en zymes are made of common domains and fall into four main groups called the collagenases, gelatinases, stromelysins, and membrane-type metalloproteinases. Their catalytic mechanism depends on a zinc ion bound at the active center; each enzyme is secreted with a propeptide that is removed proteolytically before the enzyme be comes active (6) .
Matrilysin (MMP-7), originally described as a puta tive metalloproteinase (PUMP-1), degrades type IV col lagen, laminin-1, fibronectin, proteoglycan, type I, III, IV, V gelatin, and insoluble elastin. It is also known to activate collagenase (MMP-1) to its fully activated form (6, 22) . MMP-1 degrades type I, II, III, VII, X collagen and gelatins. MMP-7 can be purified in its inactive zy mogen form of 28 kDa and as an active species of 19 kDa. It lacks the C-terminal domain common to all other metalloproteinases and is therefore the smallest.
The extracellular matrix has a profound influence on muscle morphogenesis. Although damaged muscle fi bers regenerate from a resident population of satellite cells that are wedged between the basal lamina (BL) and the muscle fiber, these satellite cells apparently pene trate poorly the BL unless it is mechanically damaged or proteolytically digested (3) . Laminin, fibronectin, proteoglycan, and collagen I, III, IV, V, VI are all asso ciated with the muscle fiber BL. The BL limits the growth and migration of activated satellite cells, orients the regeneration of new muscle fibers, and could be in volved in repressing satellite cell mitosis and differentia tion in the absence of damage (37) . The aim of the pres ent study was to investigate the effects of constitutive MMP-7 expression in mouse myoblasts on the migratory and fusogenic potential of these cells in the muscle tissue.
MATERIALS AND METHODS

Cells and Cell Culture
The parental Immortomyoblast cell line clone (clone #7) was derived from muscle biopsies of a newborn transgenic TnlLacZ immortomouse (24, 25) . The Tnl-LacZ immortomouse was obtained by interbreeding H-2k b -tsA58 transgenic mice (30) with TnlLacZ transgenic CD1 mice. H-2k b -tsA58 transgenic mice harbor a thermolabile immortalizing gene (the tsA58 mutant of SV40 large T antigen) under the control of an inducible pro moter (H-2k b ) (1) . The expression of SV40 large T anti gen is induced through application of interferon gamma (INF-y). Immortomyoblast clones (30) are grown in DMEM low-glucose medium containing 15% donor calf serum (GIBCO/BRL, Burlington, Ontario, Canada), 2% chick embryo (GIBCO), 20 U/ml INF-y, 1% (10,000 U/ ml) penicillin, 1% (10,000 U/ml) streptomycin in 8% C0 2 at 32°C in permissive conditions for the expression and function of the tsA58 gene product. Immortomy oblast clones were grown in DMEM high-glucose me dium containing 5% donor calf serum (GIBCO), 1% (10,000 U/ml) penicillin, 1% (10,000 U/ml) streptomy cin in 5% C0 2 at 37°C for nonpermissive conditions. Human myoblasts expressing normal dystrophin were obtained from fresh biopsies of patients as previously described (18) and grown in MCDB120 (18, 20) . Human primary culture myoblasts from a 12-year-old female were used for cotransplantation studies.
Plasmids and Cell Transfection
To express human matrilysin in an Immortomyoblast clone and to generate a control cell line, the matrilysin expression vector p|JAprMUTM and the control vector pRSVneo were transfected using Lipofectamine (GIBCO/BRL). p(3AprMUTM (46) contains the neomy cin selectable marker gene and a mutated form of the human matrilysin cDNA driven under the human p-actin promoter. ppAprMUTM was provided by J. D. Knox (36) and is derived from the eucaryotic expression vec tor pH-P-APr-neo-1 (16) . pRSVneo contains the neomy cin selectable marker gene under the RSV promoter (5) . One day before the transfection, 2xl0 5 Immortomyoblasts (clone #7) were plated into six-well plates and allowed to adhere overnight. Transfection of 2 ug of DNA with Lipofectamine was performed using standard procedures as specified (GIBCO/BRL). The medium was changed twice per week using complete medium containing 400 Ug/ml of Geneticin (GIBCO), beginning the selective treatment 72 h after the transfection. The transfection using the ppAprMUTM vector generated 13 Geneticin-resistant colonies, and the pRSVneo vector generated eight Geneticin-resistant colonies. Respective transfectants were pooled and expanded for freezing, analysis, and transplantation. Immortomouse myoblasts derived from the ppAprMUTM transfected cells were designated 7mat, and pRSVneo transfected myoblasts were designated 7neo; the parental cell line was called clone #7. Care was taken to experiment with Immortomyoblast cell lines at similar passage number. 
In Vitro Behavior of the Immortomyoblast Clones
Cell Preparation and Transplantation
Six SCID and 20 Balb/C mice (all females between 5 and 8 weeks old) were used as hosts for these experi ments. Both tibialis anterior (TA) were used in Balb/C mice for the implantation of immortomouse myoblast pellets from clone #7 (n = 11), 7mat (n = 13), or 7neo These cells were kept on ice until transplantation. Pellets were obtained by centrifugation at 6500 rpm for 5 min.
The skin was opened to expose the TA muscle and the myoblast pellets, resuspended in 10 pi of HBSS, were slowly injected into the belly of the TA along the rostrocaudal axis. A 0.5 cc U-100 insulin syringe (Becton Dickinson, NJ) was used for these injections, applying low pressure while the muscle was examined for leak age. Muscles showing important leakage during the in jection were not subsequently analyzed. The skin was then closed with fine sutures. FK 506 (Fujisawa Pharma ceuticals Co. Ltd., Osaka, Japan) was administered daily at 2.5 mg/kg to immunosuppress Balb/C mice (26) .
Muscle Biopsy and Preparation
Twenty-one days after myoblast transplantation, mice were deeply anesthetized with 0.15 ml of a solution con taining ketamine (10 mg/ml) and xylazine (10 mg/ml).
They were then killed by intracardiac perfusion with 0.9% saline containing heparin (2 IU/ml). The TA mus cles were dissected out and immersed in 30% sucrose solution at 4°C for 12-18 h. The specimens were imbed ded in OCT and frozen in liquid nitrogen. Serial cryostat cross sections (12 um for immunochemistry and 25 um for X-Gal staining) of the muscles were thawed on gela tin-coated slides. 
Reverse Transcriptase
Image and Statistical Analysis
Images were digitalized using a Pixera digital camera (Pixera Corp., Capertino, CA). The maximum area of circle occupied by (3-Gal-positive fibers was measured using NIH image analysis software. All area measure ments and positive fiber quantifications were performed at lOOx magnification. Serial cross sections containing the maximum amount of p-Gal-positive fibers in each muscle were used to quantify the number of positive fibers, because it most logically corresponds to the injec tion site. The surface (in mm 2 ) of the minimum circle containing all the P-Gal-positive fibers was also deter mined on the same section. RT-PCR products densitom etry was performed with NIH image analysis software, using molecular weight marker VI (Boehringer Mann heim) as internal standard for curve fitting. Significant differences were evaluated using an analysis of variance (ANOVA) followed by a Fischer's PLSD test on a Stat View 512 software (Brain Power, Calabasas, CA) with a level of p < 0.05 being considered significant.
RESULTS
Generation of Matrilysin-Expressing Immortomyoblasts
The transfection on the parental cell line, the Immor tomyoblast clone #7, with ppAprMUTM vector gener ated 13 Geneticin-resistant colonies (7mat), whereas the transfection with pRSVneo yielded eight Geneticin-re sistant control clones (7neo). The resistant transfectants of each type were pooled together to avoid drifting from the parental cell line. Myoblast cultures obtained by the transfection of the matrilysin expression vector (7mat) and the control vector (7neo) were observed and com pared with the parental cell line (clone #7). None of the stably transfected cell lines exhibited any significant modifications in their doubling time compared to clone #7 once the Geneticin selection was stopped. While 7neo and clone #7 myoblasts maintained a similar usual morphology (small, round cells) in culture, 7mat my oblasts showed a vastly increased tendency to form myotubes spontaneously in complete culture medium even at low confluence. Such fusion between those Immorto myoblast clones is rarely observed and is mostly seen in highly confluent cultures or in differentiation medium (30) .
Matrilysin Expression by Immortomyoblasts
7mat Immortomyoblasts and controls were tested for the expression of human MMP-7 by multiplex RT-PCR. Only 7mat Immortomyoblasts expressed the transgene, as shown ( Fig. 1) . Densitometry analysis showed a four fold difference in favor of the P-actin mRNA. Mouse matrilysin never interfered with our analysis; it was ei ther not expressed by the parental cell line or our detec tion techniques were specific to the human mRNA.
In Vitro Behavior of the Immortomyoblast Clones
All the Immortomyoblast cell lines have been found capable of terminal in vitro differentiation. The respec tive fusion capacity of 7mat, 7neo, and clone #7 Immor tomyoblasts was first compared by growing cells in per missive conditions for the expression and function of the tsA58 gene product. While 7neo and clone #7 Immorto myoblasts rarely formed myotubes spontaneously in per missive and nonconfluent conditions (Fig. 7A ), 7mat Immortomyoblasts fused often, even at semiconfluency (Fig. 7B) . Such a behavior was never observed with the parental clone or with any of the other Immortomyoblast clones previously isolated from the same transgenic Tnl LacZ immortomouse (unpublished data). To investigate their ability to attain final differentiation and fusion, 7mat Immortomyoblasts and controls were left in condi tions that did not permit the expression and function of the T antigen for 4 days before myotubes were counted. Myotubes were quantified by counting five microscopic fields from four duplicate wells (Fig. 2) . As observed previously, Immortomyoblast cell lines (7neo), rendered resistant to G418 by their stable transfection using mam malian expression vector, displayed a decreased fusion index compared with their parental counterpart. Strik ingly, 7mat Immortomyoblasts formed nearly three times more fibers per field then clone #7 (p< 0.0001) and seven times more fibers than control cells (p < 0.0001). In addition, myotubes formed by 7mat Immor tomyoblasts were bigger on average than those formed by control cell lines.
Transplantation of Matrilysin-Expressing Immortomyoblasts and Controls
To evaluate the effects of matrilysin expression on graft success, the three Immortomyoblast cell types were transplanted at only one site in uninjured TA muscles (n = 11) of adult mice. Twenty-one days after the trans plantation of the Immortomyoblasts, serial sections of the injected muscles were stained with X-Gal. The sec tions containing the maximum amount of P-Gal-positive fibers were selected for statistical analysis (Fig. 7C) . Positive fibers were counted in each serial section and the fusion efficacy of 7mat, 7neo, and clone #7 Immor tomyoblasts was then compared (Fig. 3) . The circular area including all P-Gal-positive fibers of all TA mus cles was also studied (Fig. 4 ). 7mat Immortomyoblasts formed significantly more (p < 0.05) P-Gal-positive fi bers. However, the surface over which 7mat Immorto myoblasts formed fibers was large, but did not reach the significance level (p = 0.11) compared with clone #7 Immortomyoblasts. Unlike clone #7 and 7mat, the con trol 7neo Immortomyoblasts did not generate any P-Galpositive fiber in any of the 11 injected TA muscles (Fig.  3) . The difference between 7mat and 7neo Immortomy oblasts was consequently highly significant (p < 0.001)
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Mat clone #7 7neo 7mat for the number of P-Gal-positive fibers generated and the covered surface ( Fig. 4) .
Cotransplantation of Matrilysin-Expressing
Immortomyoblasts With Primary Human Myoblast Cultures in SCID Mice
In an attempt to investigate whether the effect on my oblast fusion was attributable to the proteolytic activity of secreted matrilysin but not to an intracellular modifi cation only influencing the selected Immortomyoblast cells, matrilysin-expressing myoblasts were co-injected with human myoblasts. This also gave us the opportu nity to evaluate the potential of matrilysin to increase graft success for cells of a human origin. A human my oblast primary culture from a 12-year-old female was cotransplanted in SCID mice TA muscles (n = 4) with and without Immortomyoblasts expressing matrilysin (7mat). Serial sections revealed a highly increased amount of fibers and myotubes expressing human dys trophin observed in the presence of cells expressing ma trilysin, demonstrating the potential of matrilysin to in fluence the behavior of human myoblasts in a muscle (Fig. 7D, E) . A sixfold increase in the number of fibers clone 7 7 mat 7 neo Figure 3 . The surface over which P-Gal-positive fibers are observed is larger with myoblasts expressing matrilysin compared to 7neo (p < 0.001), but did not reach a significant level relative to clone #7 (p = 0.58).
or myotubes expressing human dystrophin and a four fold increase in the regenerated surface was obtained ( Fig. 6 ). Positive normal size fibers and very small fibers or myotubes were counted separately, as shown ( Fig. 5 ).
While cells expressing the matrilysin transgene in creased by a factor six the amount of human dystrophinpositive myotubes and smaller fibers, the amount of hu man dystrophin-positive fibers only doubled. Most fi bers generated contained both P-Gal activity (due to the fusion of 7mat) and human dystrophin (due to the fusion of human myoblasts). However, the P-Gal activity seemed less intense in cotransplanted muscles than in muscles only injected with Immortomyoblasts (Fig. 7F) . 
DISCUSSION
The purpose of our study was to evaluate whether matrix-degrading enzymes could stimulate the migration and the fusion of transplanted cells, therefore increasing the number of fibers expressing the donor phenotype.
Our results demonstrated that the expression of a metal- shown to confer increased fusogenic properties and to be essential for myotube formation (47) . Thus, it is likely that muscle cell fusion involves metalloproteinase-sensitive mechanisms, as previously suggested (7, 8, 22) .
Second, an increased amount of transduced fibers could result from the increased migration of transplanted myoblasts following the degradation of the ECM. The matrilysin activity might diminish the physical impair ment of the ECM, therefore augmenting the diffusion area covered by the grafted cells. The modification of the ECM in a structure promoting the migration of the myoblasts over their quiescent embedding into the ma trix could also explain increased cell diffusion (13, 14) .
Several experiments have shown that the nature of the ECM on which a myoblast is attached can affect its mo tility (13, 48) . It has been shown that laminin-1 specifi cally stimulates myoblast proliferation, locomotion (14, 33, 48) , and myogenesis in skeletal muscle (11) . Also, increased dispersion of myoblasts could be achieved by exposing promigratory peptides hidden in ECM proteins based in the BL and other ECM components in the mus- 
cle tissue. Recent results indicate that an epitope on the a-3 subunit of laminin-5, not being involved in adhe sion, directly stimulates cell motility once it is function ally unmasked by MMP-2 cleavage (13).
In addition, new data suggest that the matrilysin ac tivity is not restricted to the extracellular matrix. There are indeed evidences suggesting that MMPs are involved in the processing of TNF-a, heparin-binding epidermal growth factor, and Fas ligand (45). Therefore, it has been speculated that matrilysin may activate lumenal or membrane-bound cytokines or growth factors, such as HGF or FGFs, to perturb locally the growth of the re sponding cells (45) . Because of the complex interactions between the grafted myoblasts and the living tissue, we cannot clearly evaluate the relative importance of the potential mechanisms listed above.
Our in vivo and in vitro results suggest new hypothe ses on the apparently low percentage of injected my oblasts participating in muscle regeneration. Other teams have suggested that only a small amount of myoblasts is actually stem cells capable of surviving and proliferat ing in the muscle (1). Also, the myogenic potential of cultured myoblasts declines through multiple passages, indicating that cells with less myogenic potential are be ing selected (10). The important increase in the number of fibers expressing donor genes in the presence of ma trilysin might indicate that this decrease in regenerative potential following G418 selection is not irreversible. Noncultured, freshly isolated myoblasts were shown to form more fibers, divide faster, and migrate more than those cultured in vitro before their transplantation (10). However, genetically modified autotransplantation or MHC-compatible donor-derived myoblast transplanta tion would still require in vitro culture to generate enough numbers of cells to achieve therapy. Also, while efficient myoblast transfer has been achieved in mechan ically or chemically injured mouse muscles, the incorpo ration of myoblasts into unprepared muscles is still less efficient. Because the basal lamina and the surrounding connective tissue are more developed in dystrophic mus cles than in their normal counterparts, it may constitute a barrier to high efficiency incorporation of exogenous myoblasts (22) . This phenomenon could be of greater consequence in Duchenne patients, where connective tissue formed by and with fibroblasts occupies a greater surface (4). The expression of matrilysin in the sur roundings of grafted cells could prove to be of signifi cant help, not mainly in helping the migration of the myoblasts but in increasing the regenerating myogenic capacity of myoblasts after multiple passages. The use of metalloproteinase transgenes or ECM-degrading en zymes could possibly reduce the efficiency gap observed between freshly isolated and multiple passage my oblasts.
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